SCS Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
SCS Capital Management's RVMD Position: Q3 2026 in Review
SCS Capital Management sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 3,867 shares — an estimated $724K sold.
SCS Capital Management first reported a position in RVMD in Q4 2025 and held it in 3 quarters. The position peaked at $724K in Q2 2026. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- SCS Capital Management reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
- SCS Capital Management sold 3,867 Revolution Medicines shares in Q3 2026, an estimated $724K.
- SCS Capital Management first reported a position in Revolution Medicines in Q4 2025 and held it in 3 quarters.
- SCS Capital Management's Revolution Medicines position peaked at $724K in Q2 2026.
- 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on SCS Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.